S. Lanini, P. J. Easterbrook, A. Zumla, and G. Ippolito, Hepatitis C: global epidemiology and strategies for control, Clin Microbiol Infect, vol.22, issue.10, pp.833-841, 2016.

R. H. Westbrook and G. Dusheiko, Natural history of hepatitis C, J Hepatol, vol.61, issue.1, pp.58-68, 2014.

P. Cacoub, L. Gragnani, C. Comarmond, and A. L. Zignego, Extrahepatic manifestations of chronic hepatitis C virus infection, Dig Liver Dis, vol.46, issue.5, pp.165-73, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01159323

S. Mathew, M. Faheem, S. M. Ibrahim, W. Iqbal, B. Rauff et al., Hepatitis C virus and neurological damage, World J Hepatol, vol.8, issue.12, pp.545-56, 2016.

L. E. Adinolfi, R. Nevola, G. Lus, L. Restivo, B. Guerrera et al., Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview, World J Gastroenterol, vol.21, issue.8, pp.2269-80, 2015.

S. Iriana, M. P. Curry, and N. H. Afdhal, Neurologic manifestations of hepatitis C virus infection, Clin Liver Dis, vol.21, issue.3, pp.535-577, 2017.

H. J. Willison, B. C. Jacobs, and P. A. Van-doorn, Guillain-Barré syndrome, Lancet, vol.388, pp.717-744, 2016.

B. Van-den-berg, C. Walgaard, J. Drenthen, C. Fokke, B. C. Jacobs et al., Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis, Nat Rev Neurol, vol.10, issue.8, pp.469-82, 2014.

V. M. Cao-lormeau, A. Blake, S. Mons, S. Lastere, C. Roche et al., Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a casecontrol study, Lancet, vol.387, pp.1531-1540, 2016.

N. De-klippel, M. L. Hautekeete, D. Keyser, J. Ebinger, and G. , Guillain-Barré syndrome as the presenting manifestation of hepatitis C infection, Neurology, vol.43, issue.10, p.2143, 1993.

H. Zylberberg, H. Hagège, B. Roualdes, C. Meyrignac, and M. Chousterman, Guillain-Barré syndrome in a patient with chronic active hepatitis C, Gastroenterol Clin Biol, vol.19, issue.5, p.551, 1995.

F. Lacaille, H. Zylberberg, H. Hagège, B. Roualdès, C. Meyrignac et al., Hepatitis C associated with Guillain-Barré syndrome, Liver, vol.18, issue.1, pp.49-51, 1998.

S. A. Massengo, A. Furby, C. Stanescu, C. Charasse, and M. Madigand, Hepatitis C with cryoglobulinemia associated with Guillain-Barre syndromePresse Med, vol.30, p.739, 2001.

C. Fokke, B. Van-den-berg, J. Drenthen, C. Walgaard, P. A. Van-doorn et al., Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria, Brain, vol.137, pp.33-43, 2014.

T. W. Ho, B. Mishu, C. Y. Li, C. Y. Gao, D. R. Cornblath et al., Guillain-Barré syndrome in northern China. Relationship to campylobacter jejuni infection and anti-glycolipid antibodies, Brain, vol.118, pp.597-605, 1995.

N. Shahrizaila and Y. N. , The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action, Expert Opin Pharmacother, vol.12, issue.10, pp.1551-60, 2011.

R. D. Hadden, D. R. Cornblath, R. A. Hughes, J. Zielasek, H. P. Hartung et al., Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma exchange/Sandoglobulin Guillain-Barré syndrome trial group, Ann Neurol, vol.44, issue.5, pp.780-788, 1998.

A. Uncini and S. Kuwabara, Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update, Clin Neurophysiol, vol.123, issue.8, pp.1487-95, 2012.

N. J. Shire and K. E. Sherman, Epidemiology of hepatitis C virus. A Battle on New Frontiers, Gastroenterol Clin North Am, vol.44, issue.4, pp.699-716, 2015.

C. Ferri, M. Ramos-casals, A. L. Zignego, L. Arcaini, D. Roccatello et al., International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement, Autoimmun Rev, vol.15, issue.12, pp.1145-60, 2016.

T. J. Benstead, C. H. Chalk, and N. E. Parks, Treatment for cryoglobulinemic and noncryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection, Cochrane Database Syst Rev, issue.12, p.10404, 2014.

L. Santoro, F. Manganelli, C. Briani, F. Giannini, L. Benedetti et al., Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population, J Neurol Neurosurg Psychiatry, vol.77, issue.5, pp.626-635, 2006.

M. Pietrogrande, D. Vita, S. Zignego, A. L. Pioltelli, P. Sansonno et al., Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients, Autoimmun Rev, vol.10, issue.8, pp.444-54, 2011.

M. Ramos-casals, A. Z. Ferri, C. Brito-zerón, P. Retamozo, S. Casato et al., Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection, J Hepatol, vol.66, issue.6, pp.1282-99, 2017.

V. Khiani, T. Kelly, A. Shibli, D. Jensen, and S. R. Mohanty, Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection, World J Gastroenterol, vol.14, issue.2, pp.318-339, 2008.

M. A. Niazi, A. Azhar, K. Tufail, E. L. Feyssa, S. F. Penny et al., Guillain-Barre syndrome associated with peginterferon alfa-2a for chronic hepatitis C: a case report, World J Hepatol, vol.2, issue.4, pp.162-168, 2010.

W. N. Macleod, Sporadic non-a, non-B hepatitis and Epstein-Barr hepatitis associated with the Guillain-Barré syndrome, Arch Neurol, vol.44, issue.4, pp.438-480, 1987.

E. Tabor, Guillain-Barré syndrome and other neurologic syndromes in hepatitis A, B, and non-A, non-B, J Med Virol, vol.21, issue.3, pp.207-223, 1987.

F. Gutzler, K. Andrassy, B. Kommerell, and D. Krieger, Guillain-Barré polyneuropathy in Wegener's granulomatosis with pulmonary-renal syndrome, Dtsch Med Wochenschr, vol.115, issue.10, pp.372-379, 1990.

B. R. Wakerley, A. Uncini, and Y. N. , GBS classification group, GBS classification group. Guillain-Barré and miller fisher syndromes--new diagnostic classification, Nat Rev Neurol, vol.10, issue.9, pp.537-581, 2014.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations